Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice.
Level 5 - mechanism / opinion, no new human data
Bench and animal (mouse) mechanistic research
PubMed 31633069 · doi:10.1038/s42003-019-0607-z
What was done
Researchers investigated the role of the circadian clock gene Bmal1 in regulating cytochrome P450 3a11 (Cyp3a11) expression and drug metabolism. They used Bmal1-deficient mice and cell-based transcriptional assays to assess Cyp3a11 mRNA, protein levels, microsomal activity, and promoter binding mechanisms (including Dbp and Hnf4α interactions). They also evaluated mouse susceptibility to toxicities from aconitine and triptolide across different daily times.
What was found
The abstract reports no numerical values or effect sizes. Qualitatively, Bmal1 deficiency decreased Cyp3a11 mRNA, protein, and microsomal activity, while abolishing their normal circadian rhythms. Mechanistically, Dbp and Hnf4α activated Cyp3a11 transcription via D-box and DR1 promoter elements, with Bmal1 directly binding the Hnf4α P1 distal promoter. Bmal1-deficient mice exhibited increased drug exposure, heightened toxicity to aconitine and triptolide, and a loss of circadian variation in drug toxicity.
Why it matters
This study maps a direct molecular pathway linking the core circadian clock to Cyp3a11-mediated xenobiotic metabolism, explaining why drug toxicity varies by time of day in mice.
Limits
The study is limited to mouse models and in vitro cell cultures, so findings cannot be directly extrapolated to human CYP3A4 regulation. The abstract does not provide sample sizes, quantitative estimates, statistical error bounds, or specific drug dosing details.
Cited by
- supports Xenobiotic metabolism is strongly circadian, regulated by transcription factors that control cytochrome P450 enzymes.